The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Sullivan & Cromwell LLP

125 BROAD STREET, NEW YORK 10004-2498, USA
Work +1 212 558 4000
Fax +1 212 558 3588

S Neal McKnight

Sullivan & Cromwell LLP

Work Department

General Practice




Neal is a member of the Firm’s Corporate and Finance Group. He is co-coordinator of the Firm’s Leveraged Finance practice and a member of the Firm’s Managing Partners Committee. Neal advises financial institutions, sponsors and corporate clients on a broad range of corporate financing transactions, including debt and equity capital markets, leveraged financings, and acquisition financings. He has acted in a number of refinancing and recapitalization transactions in the bank and bond markets. His securities experience includes debt and equity offerings (including high-yield debt offerings) under Rule 144A and Regulation S, SEC-registered offerings, exchange offers, project and infrastructure bonds, and structured financings. Mr. McKnight’s clients have included Goldman Sachs, RBC, Barclays, Ontario Teachers’ Pension Plan Board, Ares Capital, Rhône Capital and United Rentals.




University of Virginia School of Law (J.D., 1996); Princeton University (M.P.A., 1996); University of North Carolina (B.A., 1990)

United States: Finance

Commercial lending

Within: Commercial lending

Sullivan & Cromwell LLP’s highly focused team has a good reputation for high-end borrower work for major public corporations such as Bayer, which it represented on its $57bn bridge loan to finance its acquisition of Monsanto; this was the third-largest acquisition bridge financing to date and the largest-ever acquisition of an American company by a foreign buyer. Another major highlight was advising AT&T on its $40bn bridge loan to finance its $85bn acquisition of Time Warner. The team, which is led by Robert Downes, John Estes and S Neal McKnight, has a very broad skillset and is equally comfortable in the high-yield space as it is for acquisition finance. This was demonstrated in its advice to Concordia, which used a combination of a $520m equity raising and a debt financing, including a $790m high-yield bond and a $1.87bn senior secured term loan to finance its acquisition of Amdipharm Mercury. Other highly rated partners include Ari Blaut and Erik Lindauer.

[back to top]

Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to